Submitted by web@researchtop... on Fri, 07/23/2010 - 09:10
Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myelogenous Leukemia (CML-CP)
| CME test | Downloadable PDF | PowerPoint slides | CME Information and Faculty Disclosures |
| Read Dr Love's original email (from July 26, 2010) | Subscribe to Dr Love's email alerts | ||
Slides from a presentation at ASCO 2010 and transcribed comments from a recent interview with Hagop M Kantarjian, MD (6/30/10)
Kantarjian H et al. Dasatinib compared to imatinib in patients with newly diagnosed chronic myelogenous leukemia in chronic-phase (CML-CP): Twelve-month efficacy and safety from the phase III DASISION study. Proc ASCO 2010;Abstract LBA6500.
Kantarjian H et al. Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2010;362(24):2260-70. Abstract